|
    GNS U.K.: London

    Genus PLC

    GNSUK
    Open
    Last Updated: Sep 8, 2023 9:51 a.m. BST Delayed quote

    p 2,114.00

    52.00 2.52%
    Previous Close
    2,062.00p
    Advanced Charting
    Volume: 57.21K 65 Day Avg: 150.95K
    38% vs Avg
    2,054.00 Day Range 2,124.00
    2,050.00 52 Week Range 3,364.00

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    GNS Overview

    Key Data

    • Open 2,058.00p
    • Day Range 2,054.00 - 2,124.00
    • 52 Week Range 2,050.00 - 3,364.00
    • Market Cap £1.46B
    • Shares Outstanding 66.03M
    • Public Float 64.58M
    • Beta 0.57
    • Rev. per Employee N/A
    • P/E Ratio 41.90
    • EPS £0.50
    • Yield 1.51%
    • Dividend 10.30p
    • Ex-Dividend Date Mar 2, 2023
    • Short Interest N/A
    • % of Float Shorted N/A
    • Average Volume 150.95K

    Performance

    5 Day
    • -8.09%
    1 Month
    • -10.12%
    3 Month
    • -13.00%
    YTD
    • -29.16%
    1 Year
    • -26.08%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 6 Full Ratings

    No Headlines Available

    Genus PLC

    Genus Plc engages in the provision of genetic livestock services to produce meat and milk. It operates through the following segments: Genus PIC, Genus ABS and Research and Development. The Genus PIC segment focuses on global porcine sales business. The Genus ABS segment includes global bovine sales business. The Research and Development segment involves in global spend on research and development. The company was founded in 1994 and is headquartered in Basingstoke, the United Kingdom.